Literature DB >> 12502503

Effects of acute insulin excess and deficiency on gluconeogenesis and glycogenolysis in type 1 diabetes.

Guenther Boden1, Peter Cheung, Carol Homko.   

Abstract

To determine whether insulin induces acute changes in endogenous glucose production (EGP) via changes in gluconeogenesis (GNG), glycogenolysis (GL), or both, we measured GNG (with (2)H(2)O) and GL (EGP-GNG) in nine patients with type 1 diabetes during acute insulin excess produced by subcutaneous injection of insulin and during insulin deficiency which developed between 5 and 8 h after insulin injection. During insulin excess, free insulin concentration rose fivefold (from 36 to 180 pmol/l). Plasma glucose was maintained between 6.2 and 6.7 mmol/l for approximately 4 h with IV glucose. EGP (with 6,6-(2)H glucose) decreased from 17.1 to 9.8 micro mol. kg(-1). min(-1) after 1 h. This decrease was almost completely accounted for by a decrease in GL (from 10.7 to 4.6 micro mol. kg(-1). min(-1)). During insulin deficiency, plasma glucose rose from 6.2 to 10.5 mmol/l and EGP from 9.5 to 14.3 micro mol/kg min. The increase in EGP again was accounted for by an increase in GL. We conclude that in type 1 diabetes acute regulation of EGP by insulin is mainly via changes in GL while GNG changes little during the early hours of acute insulin excess or deficiency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502503     DOI: 10.2337/diabetes.52.1.133

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo.

Authors:  Christopher J Ramnanan; Dale S Edgerton; Noelia Rivera; Jose Irimia-Dominguez; Ben Farmer; Doss W Neal; Margaret Lautz; E Patrick Donahue; Catalina M Meyer; Peter J Roach; Alan D Cherrington
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

2.  Insulin's direct hepatic effect explains the inhibition of glucose production caused by insulin secretion.

Authors:  Dale S Edgerton; Guillaume Kraft; Marta Smith; Ben Farmer; Phillip E Williams; Katie C Coate; Richard L Printz; Richard M O'Brien; Alan D Cherrington
Journal:  JCI Insight       Date:  2017-03-23

3.  Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes.

Authors:  Ian R Lanza; Shucha Zhang; Lawrence E Ward; Helen Karakelides; Daniel Raftery; K Sreekumaran Nair
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

4.  Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes.

Authors:  F Smeeton; F Shojaee Moradie; R H Jones; L Westergaard; H Haahr; A M Umpleby; D L Russell-Jones
Journal:  Diabetologia       Date:  2009-08-26       Impact factor: 10.122

Review 5.  Basal insulin therapy.

Authors:  John N Clore; Linda Thurby-Hay
Journal:  Curr Diab Rep       Date:  2004-10       Impact factor: 4.810

Review 6.  Which basal insulin should be used in patients with type 2 diabetes mellitus?

Authors:  John N Clore; Linda Thurby-Hay
Journal:  Curr Diab Rep       Date:  2007-10       Impact factor: 4.810

7.  Short-term effects of recombinant human growth hormone and feeding on gluconeogenesis in humans.

Authors:  Walid Kaplan; Agneta L Sunehag; Harry Dao; Morey W Haymond
Journal:  Metabolism       Date:  2008-06       Impact factor: 8.694

8.  Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats.

Authors:  Shucha Zhang; G A Nagana Gowda; Vincent Asiago; Narasimhamurthy Shanaiah; Coral Barbas; Daniel Raftery
Journal:  Anal Biochem       Date:  2008-08-20       Impact factor: 3.365

9.  In silico evaluation of a control system and algorithm for automated insulin infusion in the ICU setting.

Authors:  José L Ortiz; Marcelo W Guarini; Gisella R Borzone; Pablo R Olmos
Journal:  Biomed Eng Online       Date:  2010-07-20       Impact factor: 2.819

10.  Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo.

Authors:  Dale S Edgerton; Christopher J Ramnanan; Carrie A Grueter; Kathryn M S Johnson; Margaret Lautz; Doss W Neal; Phillip E Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2009-09-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.